article thumbnail

GSK’s world-first gonorrhoea vaccine launched in England

Pharmaceutical Technology

Robert Barrie August 5, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook In 2023, a record 85,000 cases of the disease were reported in England — three times higher than in 2012. In 2023, a record 85,000 cases of the disease were reported in England — three times higher than in 2012.

article thumbnail

Alfasigma sets stage for Jyseleca in axSpA after Phase III win

Pharmaceutical Technology

The first partnership with the therapy was between original developer Galapagos and Abbot Laboratories in 2012, when the therapy was in Phase II development in RA. Jyseleca in third development partnership The development of Jyseleca has seen several shifts in the pharmaceutical industry.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Is DTC pharma advertising coming to an end?

PharmaVoice

An attempt by the agency to prohibit pharma ads was shot down by a court in 2012, for example, on the grounds that they’re protected by First Amendment rights, Politico reported. But a ban enacted through legislation is more likely to hold up in court than a policy change by the FDA. Is DTC pharma advertising coming to an end?

article thumbnail

FDA creates new priority review voucher scheme to boost US interests

Pharmaceutical Technology

The PRV programme for rare paediatric diseases, signed into law in 2012, expired in late 2024 after it failed to make it into a US Congress funding package. This effectively pushed the programme into its ‘sunsetting phase’. Give your business an edge with our leading industry insights.

FDA
article thumbnail

Bavarian Nordic nets $160m from priority review voucher sale

Pharmaceutical Technology

By GlobalData Learn more about Strategic Intelligence Sale figures increasing after dip PRVs were introduced in 2012 to incentivise development into non-lucrative disease areas. Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis. Give your business an edge with our leading industry insights.

FDA
article thumbnail

Beyond instruments: streamlining process technology implementation in biopharmaceutical manufacturing

European Pharmaceutical Review

Given that multiple work packages may often start or end together, or else take longer than others ( Figure 1 ), the introduction of new PAT requires assessment and planning by multiple departments. International Council for Harmonisation (ICH), 2012. International Council for Harmonisation (ICH), 2005. Q9 Quality Risk Management.

article thumbnail

Regulating decentralised manufacturing in the UK – a legal perspective

European Pharmaceutical Review

In the EU, the EU pharmaceutical package of reform 5 includes a proposed new Directive, 6 which will replace the current Medicines Directive (2001/83/EC). Available from: [link] Human Medicines Regulations 2012 and Medicines for Human Use (Clinical Trials) Regulations 2004. Internet] UK Government. Under the Human Tissue Act 2004.